10-Q: Joint Corp. Swings to Profit Amid Refranchising Push

The Joint Corp. reported a net income of $1.06 million for the first six months of 2025, a significant turnaround driven by its refranchising strategy and growth in its franchise operations.

Summary

• Net income for the six months ended June 30, 2025, was $1.06 million, a substantial improvement from a net loss of $2.65 million in the prior year period.
• Total revenues from continuing operations increased by 6.3% to $26.35 million for the six months ended June 30, 2025, compared to $24.79 million in the same period last year.
• The company refranchised 37 clinics in the second quarter of 2025, including 31 clinics in Arizona and New Mexico for $8.3 million in cash and regional developer territory rights, and 5 clinics in Kansas City.
• Adjusted EBITDA for the six months ended June 30, 2025, rose to $6.09 million from $5.63 million in the prior year.
• System-wide sales for all clinics grew 2.6% to $129.6 million for the three months ended June 30, 2025.
• Comparable same-store sales for clinics open at least 13 months increased by 1.4% for the three months ended June 30, 2025, while mature clinics (open 48+ months) saw a 2.0% decrease.
• Cash and cash equivalents increased to $29.81 million as of June 30, 2025, from $25.05 million at December 31, 2024.
• A material weakness in internal controls over financial reporting related to accounting for non-routine transactions and asset impairment valuations continues to exist.

Sentiment

Score: 7

Explanation: The company's significant swing to net income, driven by successful refranchising and continued revenue growth in its core franchise operations, indicates positive strategic execution. However, the persistent material weakness in internal controls and the challenging macroeconomic environment introduce elements of caution.

Positives

• Achieved a net income of $1.06 million for the first six months of 2025, a significant improvement from a $2.65 million net loss in the prior year.
• Total revenues from continuing operations increased by 6.3% to $26.35 million for the six months ended June 30, 2025, driven by franchise expansion and sales growth.
• Adjusted EBITDA from continuing and discontinued operations increased to $6.09 million for the six months ended June 30, 2025, up from $5.63 million in the prior year.
• Successfully refranchised 37 company-owned or managed clinics in Q2 2025, generating $7.8 million in proceeds from sales of clinics for the six months ended June 30, 2025.
• Franchise licenses sold increased to 13 in Q2 2025, up from 7 in Q2 2024, indicating accelerated franchise growth.
• Comparable same-store sales for clinics open at least 13 months increased by 1.4% for the three months ended June 30, 2025.
• System-wide sales grew 2.6% to $129.6 million for the three months ended June 30, 2025.
• Cash and cash equivalents increased to $29.81 million as of June 30, 2025, from $25.05 million at December 31, 2024.
• No outstanding balance on the Credit Agreement as of June 30, 2025, following a $2.0 million paydown in January 2024.

Negatives

• Net cash used in operating activities for the six months ended June 30, 2025, was $2.83 million, a decrease from $1.84 million provided by operating activities in the prior year.
• Comparable same-store sales for mature clinics (open 48 months or more) decreased by 2.0% for the three months ended June 30, 2025.
• General and administrative expenses, while decreasing in absolute terms, still represent a significant portion of revenue (56% for six months ended June 30, 2025).
• The company continues to face a material weakness in internal controls over financial reporting related to complex transactions and asset impairment valuations.
• The macroeconomic environment is anticipated to remain volatile in 2025, with ongoing labor shortages and inflation impacting labor costs and potentially consumer spending.

Risks

• Nationwide labor shortages negatively impact the ability to recruit chiropractors and qualified personnel, potentially limiting growth and reducing net revenues due to increased wages.
• Inflation, leading to increased labor costs and interest rates, and changes to import tariffs, may reduce discretionary spending and negatively impact the business.
• Inability to successfully implement the growth strategy if franchisees cannot secure appropriate sites, obtain favorable lease terms, or attract patients.
• Restatement of prior consolidated financial statements may lead to additional risks, including loss of investor confidence and negative impacts on stock price.
• Limited experience operating company-owned or managed clinics in new geographic areas may hinder the ability to duplicate franchisee success.
• Failure to remediate the identified material weakness in internal controls over financial reporting or maintain an effective system could negatively impact financial reporting accuracy, fraud prevention, or investor confidence.
• Potential failure to successfully design, maintain, or implement proprietary and third-party management information systems.
• Inability to maintain data integrity or strategically implement, upgrade, or consolidate existing information systems.
• Inability to continue selling franchises to qualified franchisees or for franchisees to succeed in developing profitable territories and clinics.
• New clinics may not reach profitability, and the company may not maintain or improve revenues and franchise fees from existing franchised clinics.
• High competition in the chiropractic industry from many well-established independent competitors could prevent market share increase or lead to reduction.
• State administrative actions and rulings regarding corporate practice of chiropractic and prepayment of services may jeopardize the business model.
• Expected new federal regulations and state laws regarding joint employer responsibility could negatively impact the franchise model, increasing liability for franchisee employment law violations.
• Increased regulatory focus on fair franchise practices could increase liability risk in disputes with franchisees and enforcement actions.
• Negative publicity or damage to reputation from opponents of chiropractic or traditional service models could adversely impact operations and financial position.
• Breaches of IT security systems (including third-party providers) could lead to civil liability and diminished public perception, affecting patient attraction and retention.
• Legislation, regulations, and new medical procedures/techniques could reduce or eliminate competitive advantages.

Future Outlook

The company anticipates 2025 will continue to be a volatile macroeconomic environment, with ongoing labor shortages and inflation impacting labor costs and potentially consumer spending. It plans to leverage its refranchising efforts to generate value-creating capital allocation opportunities, including reinvestment in the brand, IT platforms, regional development territory repurchases, M&A, and stock repurchase programs. The company believes its existing cash, anticipated cash flows, and credit line will be sufficient for operating and investment needs for at least the next 12 months.

Management Comments

• "We will continue our rapid and franchised-focused expansion of chiropractic clinics in key markets throughout North America, and potentially abroad, as we seek to be the leading provider of chiropractic care in the markets we serve and to become the most recognized brand in our industry."
• "Our refined strategy will leverage our greatest strength our capacity to build a franchise to drive long-term growth for both our franchisees and The Joint as a public company."
• "We have created a robust framework for the refranchising effort, organizing clinics into clusters, and generating comprehensive disclosure packets for marketing efficiency, and that we have received significant interest to date from our existing franchisees."
• "Our goal will be to generate significant processes that will provide us with value creating capital allocation opportunities, which opportunities could include, but are not limited to, reinvestment in the brand and related marketing, continued investment in our IT platforms, the repurchase of regional development territories, certain merger or acquisition opportunities and/or a stock repurchase program."
• "We believe that we continue to have a sound business concept and will benefit from the fundamental changes taking place in the manner in which Americans access chiropractic care and their growing interest in seeking effective, affordable natural solutions for general wellness."
• "We anticipate that 2025 will continue to be a volatile macroeconomic environment."
• "We believe that our existing cash and cash equivalents, our anticipated cash flows from operations and amounts available under our line of credit will be sufficient to fund our anticipated operating and investment needs for at least the next 12 months."

Industry Context

The company operates in the chiropractic care industry, which is experiencing fundamental changes in how Americans access care, with a growing interest in affordable natural wellness solutions. The company's cash-based, non-insurance model aligns with a preference among chiropractic doctors to move away from insurance-based models, creating an opportunity for network growth. The industry, however, faces macroeconomic headwinds such as labor shortages and inflation, which increase operating costs and may reduce consumer discretionary spending on services.

Management Changes

Corporate Governance

Legal Proceedings

• Settlement agreements from litigation related to employment matters of $1.5 million were entered into during the second quarter of 2024, accrued in discontinued operations current liabilities.
• A medical injury claim filed on September 5, 2023, reached a settlement agreement on February 25, 2025, for $3.4 million, which was accrued as of December 31, 2024, and paid in full during Q1 2025, partially offset by a $1.9 million insurance receivable.

Related Party Transactions

• Mr. Jefferson Gramm, a Board Director and Managing Partner of Bandera Partners LLC (beneficial holder of approximately 26% common stock), has a family member (Marshall Gramm) who owns four franchise licenses.
• One license was sold to Mr. Marshall Gramm in December 2020 for $39,900.
• Three licenses were transferred to Mr. Marshall Gramm in June 2022 for a transfer fee of $15,000 each plus prorated franchise license fees of $17,706 total.
• These transactions involved terms no less favorable than those with unaffiliated parties.
• In October 2020, Mr. Gramm loaned approximately $370,000 to an unaffiliated franchisee, with a remaining balance of approximately $215,000 as of June 30, 2025.

Stakeholder Impact

• Shareholders: Positive impact from the swing to net income and successful refranchising, potentially leading to value creation through capital allocation opportunities. However, the material weakness in internal controls and macroeconomic uncertainties pose risks.
• Franchisees: Continued expansion and support for the franchise model, with regional developer programs accelerating growth. Refranchising of corporate clinics provides opportunities for existing franchisees to expand.
• Employees: Impact from refranchising, with company-owned clinic employees potentially transitioning to new franchisee employers. Labor shortages and wage increases affect employee compensation and recruitment.
• Customers/Patients: Continued access to chiropractic care through an expanding franchise network. Potential impact from pricing actions to mitigate increased labor costs.
• Creditors: Improved financial health with no outstanding debt on the Credit Agreement as of June 30, 2025, reducing immediate credit risk.

Next Steps

• Continue rapid and franchised-focused expansion of chiropractic clinics in key markets.
• Refranchise the balance of the corporate clinic portfolio, with approximately all expected to be sold within one year.
• Leverage the regional developer program to accelerate clinic sales and openings.
• Evaluate and pursue value-creating capital allocation opportunities, including brand reinvestment, IT platform investment, regional development territory repurchases, M&A, and stock repurchase programs.
• Remediate the identified material weakness in internal controls over financial reporting by designing and implementing enhanced controls for non-routine transactions and impairment valuations.
• Evaluate the impact of the recently enacted H.R. 1, the One Big Beautiful Bill Act, on future tax provisions.
• Execute a development agreement for an additional nine clinics with Joint Ventures, LLC, and an additional development agreement for one clinic with terms to be mutually agreed upon.
• Update branding and refresh clinics according to the Revised Refresh Schedule.
• Close the Apache Junction clinic and transfer patient records to East Mesa.
• Work in good faith to comply with all requirements for the sale of acquired assets and applicable state/local laws.
• Engage in commercially reasonable efforts to approve a pass-through of New Mexico Gross Receipts Tax to consumers and revise contracts accordingly.
• Use commercially reasonable efforts to timely complete a change in the point-of-sale system to accommodate the New Mexico Gross Receipts Tax pass-through.

Key Dates

Recommendation

The company's strategic refranchising efforts are yielding positive financial results, evidenced by the swing to net income and increased Adjusted EBITDA. The growth in franchised clinics and system-wide sales indicates a healthy core business model. However, the persistent material weakness in internal controls over financial reporting, coupled with a decrease in mature clinic comparable sales and a negative cash flow from operating activities, suggests underlying operational challenges and risks. The macroeconomic volatility, labor shortages, and inflation also present headwinds. While the refranchising strategy is promising for long-term growth and capital allocation, the unresolved internal control issues and mixed operational metrics warrant a cautious 'hold' stance until further clarity on remediation and sustained operational improvements are demonstrated.

Keywords

Chiropractic, Franchising, Healthcare, SEC Filing, Financial Results, Refranchising, Clinic Sales, Adjusted EBITDA, System-wide Sales, Comparable Sales, Internal Controls, Labor Shortage, Inflation, Risk Management, Corporate Governance